{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-009231","form_type":"8-K","ticker":"LUCD","cik":"0001799011","company_name":"Lucid Diagnostics Inc.","filed_at":"2025-03-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.910781+00:00","generated_at":"2026-05-25T10:57:50.194907+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Lucid Diagnostics closes $15.3M registered direct offering of 13.9M shares at $1.10/share","bullets":["Closed offering of 13,939,331 common shares at $1.10 per share for gross proceeds of $15.3M.","Net proceeds after fees and expenses estimated at $14.5M; Canaccord Genuity acted as sole placement agent.","Funds to be used for working capital and other general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-009231","json":"https://secwatch.observer/filing/0001493152-25-009231.json","markdown":"https://secwatch.observer/filing/0001493152-25-009231.md","text":"https://secwatch.observer/filing/0001493152-25-009231.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799011/000149315225009231/0001493152-25-009231-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799011/000149315225009231/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T10:57:50.194907+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}